These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 16225937)

  • 1. TcPDE4, a novel membrane-associated cAMP-specific phosphodiesterase from Trypanosoma cruzi.
    Alonso GD; Schoijet AC; Torres HN; Flawiá MM
    Mol Biochem Parasitol; 2006 Jan; 145(1):40-9. PubMed ID: 16225937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TcrPDEA1, a cAMP-specific phosphodiesterase with atypical pharmacological properties from Trypanosoma cruzi.
    Alonso GD; Schoijet AC; Torres HN; Flawiá MM
    Mol Biochem Parasitol; 2007 Mar; 152(1):72-9. PubMed ID: 17222469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDE4B5, a novel, super-short, brain-specific cAMP phosphodiesterase-4 variant whose isoform-specifying N-terminal region is identical to that of cAMP phosphodiesterase-4D6 (PDE4D6).
    Cheung YF; Kan Z; Garrett-Engele P; Gall I; Murdoch H; Baillie GS; Camargo LM; Johnson JM; Houslay MD; Castle JC
    J Pharmacol Exp Ther; 2007 Aug; 322(2):600-9. PubMed ID: 17519386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification, characterization and subcellular localization of TcPDE1, a novel cAMP-specific phosphodiesterase from Trypanosoma cruzi.
    D'Angelo MA; Sanguineti S; Reece JM; Birnbaumer L; Torres HN; Flawiá MM
    Biochem J; 2004 Feb; 378(Pt 1):63-72. PubMed ID: 14556647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of PDE8A, a novel human cAMP-specific phosphodiesterase.
    Fisher DA; Smith JF; Pillar JS; St Denis SH; Cheng JB
    Biochem Biophys Res Commun; 1998 May; 246(3):570-7. PubMed ID: 9618252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of a mutation in phosphodiesterase type 4 that alters both inhibitor activity and nucleotide selectivity.
    Herman SB; Juilfs DM; Fauman EB; Juneau P; Menetski JP
    Mol Pharmacol; 2000 May; 57(5):991-9. PubMed ID: 10779384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells.
    Verghese MW; McConnell RT; Lenhard JM; Hamacher L; Jin SL
    Mol Pharmacol; 1995 Jun; 47(6):1164-71. PubMed ID: 7603456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a novel cAMP-binding, cAMP-specific cyclic nucleotide phosphodiesterase (TcrPDEB1) from Trypanosoma cruzi.
    Díaz-Benjumea R; Laxman S; Hinds TR; Beavo JA; Rascón A
    Biochem J; 2006 Oct; 399(2):305-14. PubMed ID: 16776650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the functional domains of human recombinant phosphodiesterase 4A: structural requirements for catalytic activity and rolipram binding.
    Jacobitz S; McLaughlin MM; Livi GP; Burman M; Torphy TJ
    Mol Pharmacol; 1996 Oct; 50(4):891-9. PubMed ID: 8863835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression, purification, and characterization of human cAMP-specific phosphodiesterase (PDE4) subtypes A, B, C, and D.
    Wang P; Myers JG; Wu P; Cheewatrakoolpong B; Egan RW; Billah MM
    Biochem Biophys Res Commun; 1997 May; 234(2):320-4. PubMed ID: 9177268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and characterization of the human and mouse PDE7B, a novel cAMP-specific cyclic nucleotide phosphodiesterase.
    Gardner C; Robas N; Cawkill D; Fidock M
    Biochem Biophys Res Commun; 2000 May; 272(1):186-92. PubMed ID: 10872825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A FYVE-containing unusual cyclic nucleotide phosphodiesterase from Trypanosoma cruzi.
    Kunz S; Oberholzer M; Seebeck T
    FEBS J; 2005 Dec; 272(24):6412-22. PubMed ID: 16336277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation and induction of cyclic AMP phosphodiesterase (PDE4) in rat pulmonary microvascular endothelial cells.
    Zhu B; Kelly J; Vemavarapu L; Thompson WJ; Strada SJ
    Biochem Pharmacol; 2004 Aug; 68(3):479-91. PubMed ID: 15242814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A reporter gene assay for screening of PDE4 subtype selective inhibitors.
    Bora RS; Malik R; Arya R; Gupta D; Singh V; Aggarwal N; Dastidar S; Ray A; Saini KS
    Biochem Biophys Res Commun; 2007 Apr; 356(1):153-8. PubMed ID: 17336928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of human recombinant cAMP phosphodiesterase isozyme IV reverses growth arrest phenotypes in phosphodiesterase-deficient yeast.
    McHale MM; Cieslinski LB; Eng WK; Johnson RK; Torphy TJ; Livi GP
    Mol Pharmacol; 1991 Feb; 39(2):109-13. PubMed ID: 1847489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and characterization of deletion recombinants of two cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE-3).
    He R; Komas N; Ekholm D; Murata T; Taira M; Hockman S; Degerman E; Manganiello VC
    Cell Biochem Biophys; 1998; 29(1-2):89-111. PubMed ID: 9631240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cells.
    Growcott EJ; Spink KG; Ren X; Afzal S; Banner KH; Wharton J
    Respir Res; 2006 Jan; 7(1):9. PubMed ID: 16423283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of substrate specificity determinants in human cAMP-specific phosphodiesterase 4A by single-point mutagenesis.
    Richter W; Unciuleac L; Hermsdorf T; Kronbach T; Dettmer D
    Cell Signal; 2001 Mar; 13(3):159-67. PubMed ID: 11282454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation.
    Tiwari S; Dong H; Kim EJ; Weintraub L; Epstein PM; Lerner A
    Biochem Pharmacol; 2005 Feb; 69(3):473-83. PubMed ID: 15652238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors.
    Rutten K; Prickaerts J; Hendrix M; van der Staay FJ; Sik A; Blokland A
    Eur J Pharmacol; 2007 Mar; 558(1-3):107-12. PubMed ID: 17207788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.